Back to search
B-Cell Non-Hodgkin Lymphoma (B-NHL)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which B-Cell Non-Hodgkin Lymphoma (B-NHL) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which B-Cell Non-Hodgkin Lymphoma (B-NHL) trials you may qualify forStudy consists of two main parts to explore BGB-16673 recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy dose escalation and monoth…
This phase II trial studies the safety and how well of loncastuximab tesirine when given together with mosunetuzumab works in treating patients with diffuse lar…
This phase II trial tests whether loncastuximab tesirine works to shrink tumors in patients with B-cell malignancies that have come back (relapsed) or does not…
This is a Phase 1b/2, multicenter, open-label, study of prizloncabtagene autoleucel (prizlo-cel), an autologous dual targeting chimeric antigen receptor (CAR) T…
This study is being done to determine the safety, efficacy and tolerability of a single 50 mCi dose of 131I-Apamistamab given prior to FDA approved (commerciall…
This is a Phase I/II open-label, global multicenter study to evaluate the safety and efficacy of AZD4512 monotherapy or in combination with other anticancer age…
This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on patients with previously treated aggressi…
This randomized phase II trial studies the safety and how well multi-peptide cytomegalovirus (CMV)-modified vaccinia Ankara (MVA) vaccine works in reducing CMV…